BP Ousts Chairman Albert Manifold Amid Persistent Boardroom Turmoil STSS Q3 2025 Earnings EPS Misses Estimates by Wide Margin as Company Remains PreRevenue Sarepta Therapeutics Maps 2026 Priorities from Strong Cash Position